Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Bronwen E. Shaw MBChB, PhD

Bronwen E. Shaw MBChB, PhD

Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

Member of the Cancer Center


Publications

  • PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. (Shaw BE, Syrjala KL, Onstad LE, Chow EJ, Flowers ME, Jim H, Baker KS, Buckley S, Fairclough DL, Horowitz MM, Lee SJ) Cancer 2017 Oct 26 PMID: 29072787 10/27/2017
  • Donation of peripheral blood stem cells to unrelated strangers: A thematic analysis. (Billen A, Madrigal JA, Scior K, Shaw BE, Strydom A) PLoS One 2017;12(10):e0186438 PMID: 29069088 PMCID: PMC5656410 10/27/2017
  • Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34(+) Yields Are Less. (Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2017 Sep 25 PMID: 28958894 09/30/2017
  • Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Group for Blood and Marrow Transplantation. (Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE) Biol Blood Marrow Transplant 2017 Sep 20 PMID: 28939455 09/25/2017
  • Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. (Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD) Cancer 2017 Aug 17 PMID: 28817182 08/18/2017
  • Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. (Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR) Biol Blood Marrow Transplant 2017 Nov;23(11):1955-1960 PMID: 28757436 08/02/2017
  • Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. (Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NN) Am J Hematol 2017 Oct;92(10):E610-E611 PMID: 28699171 07/13/2017
  • Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation. (Berro M, Arbelbide JA, Rivas MM, Basquiera AL, Ferini G, Vitriu A, Foncuberta C, Fernandez Escobar N, Requejo A, Milovic V, Yantorno S, Szelagoswki M, Martinez Rolon J, Bentolila G, Garcia JJ, Garcia P, Caeiro G, Castro M, Jaimovich G, Palmer S, Trucco JI, Bet LA, Shaw BE, Kusminsky GD) Biol Blood Marrow Transplant 2017 Oct;23(10):1646-1650 PMID: 28669923 07/04/2017
  • HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities. (Fleischhauer K, Shaw BE) Blood 2017 Aug 31;130(9):1089-1096 PMID: 28667011 07/02/2017
  • Parent versus child donor perceptions of the bone marrow donation experience. (Switzer GE, Bruce J, Pastorek G, Kiefer DM, Kobusingye H, Drexler R, Besser RAM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni JW, Pulsipher MA) Bone Marrow Transplant 2017 Sep;52(9):1338-1341 PMID: 28650449 06/27/2017
  • Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation. (Fleischhauer K, Ahn KW, Wang HL, Zito L, Crivello P, Müller C, Verneris M, Shaw BE, Pidala J, Oudshorn M, Lee SJ, Spellman SR) Bone Marrow Transplant 2017 Sep;52(9):1280-1287 PMID: 28581467 06/06/2017
  • Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age. (Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dandoy C, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, Yu LC, Warwick A, Shaw B, Duncan C) Biol Blood Marrow Transplant 2017 Aug;23(8):1327-1334 PMID: 28461213 PMCID: PMC5666571 05/04/2017
  • Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes. (Hamblin A, Greenfield DM, Gilleece M, Salooja N, Kenyon M, Morris E, Glover N, Miller P, Braund H, Peniket A, Shaw BE, Snowden JA) Bone Marrow Transplant 2017 Jun;52(6):889-894 PMID: 28436977 04/25/2017
  • Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). (Gabriel M, Shaw BE, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li CK, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw PJ) Biol Blood Marrow Transplant 2017 Aug;23(8):1320-1326 PMID: 28411175 PMCID: PMC5518678 04/16/2017
  • Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation. (Berro M, Palau Nagore MV, Rivas MM, Longo P, Foncuberta C, Vitriú A, Remaggi G, Martínez Rolon J, Jaimovich G, Requejo A, Feldman L, Padros K, Rodríguez MB, Shaw BE, Larripa I, Belli CB, Kusminsky GD) Bone Marrow Transplant 2017 May;52(5):739-744 PMID: 28134923 01/31/2017
  • Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants. (Shaw BE, Mayor NP, Szydlo RM, Bultitude WP, Anthias C, Kirkland K, Perry J, Clark A, Mackinnon S, Marks DI, Pagliuca A, Potter MN, Russell NH, Thomson K, Madrigal JA, Marsh SGE) Bone Marrow Transplant 2017 May;52(5):717-725 PMID: 28092349 01/17/2017
  • CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. (Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey TR, Jacobsen N, Kröger N, Walker I, Light S, Shaw BE, Beato F, Laport GG, Nademanee A, Keating A, Socie G, Anasetti C) Biol Blood Marrow Transplant 2017 Mar;23(3):405-411 PMID: 28007665 12/23/2016
  • Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni JW, Pulsipher MA) J Pediatr 2016 Nov;178:164-170.e1 PMID: 27522440 PMCID: PMC5085860 10/30/2016
  • Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA) Biol Blood Marrow Transplant 2017 Jan;23(1):165-171 PMID: 27751935 PMCID: PMC5182103 10/19/2016
  • Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. (Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M) Bone Marrow Transplant 2016 Dec;51(12):1602-1604 PMID: 27595288 09/07/2016
  • Variations in practice in UK transplant centers: results of a related donor care survey. (Anthias C, Peniket A, Kirkland K, Madrigal JA, Shaw BE) Bone Marrow Transplant 2016 Dec;51(12):1612-1614 PMID: 27595287 09/07/2016
  • National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report. (Shaw BE, Hahn T, Martin PJ, Mitchell SA, Petersdorf EW, Armstrong GT, Shelburne N, Storer BE, Bhatia S) Biol Blood Marrow Transplant 2017 Jan;23(1):10-23 PMID: 27590102 PMCID: PMC5182148 09/04/2016
  • Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. (DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers ME, Savani BN, Shaw BE) Bone Marrow Transplant 2017 Feb;52(2):173-182 PMID: 27548466 PMCID: PMC5288134 08/23/2016
  • Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C) JAMA Oncol 2016 Dec 01;2(12):1583-1589 PMID: 27532508 PMCID: PMC5145732 08/18/2016
  • Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. (DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE, CIBMTR Late Effects and Quality of Life Working Committee, EBMT Complications and Quality of Life Working Party) Biol Blood Marrow Transplant 2016 Aug;22(8):1493-1503 PMID: 27184625 PMCID: PMC4949101 05/18/2016
  • Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. (Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE) Bone Marrow Transplant 2016 Sep;51(9):1173-9 PMID: 27159181 05/10/2016
  • Safety of Living Donation of Hematopoietic Stem Cells. (Szer J, Elmoazzen H, Fechter M, Hwang W, Korhonen M, Miller J, Mengling T, Shaw B, Stein J) Transplantation 2016 Jun;100(6):1329-31 PMID: 27136264 05/03/2016
  • Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation. (Li Z, Rubinstein SM, Thota R, Savani M, Brissot E, Shaw BE, Majhail NS, Mohty M, Savani BN) Biol Blood Marrow Transplant 2016 Aug;22(8):1368-1375 PMID: 27095688 04/21/2016
  • BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. (Dignan FL, Clark A, Aitken C, Gilleece M, Jayakar V, Krishnamurthy P, Pagliuca A, Potter MN, Shaw B, Skinner R, Turner A, Wynn RF, Coyle P, Haemato-oncology Task Force of the British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation and the UK Clinical Virology Network) Br J Haematol 2016 May;173(3):380-93 PMID: 27060988 04/12/2016
  • Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned. (Sorensen BS, Szer J, Shaw B, Korhonen M, Mengling T, Fechter M, Elmoazzen H, Lindberg B, Chapman J, Nørgaard JM, Foeken L, Hwang WY, Nielsen B) Bone Marrow Transplant 2016 Jul;51(7):1016-8 PMID: 26974269 03/15/2016
  • Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield. (Anthias C, Billen A, Arkwright R, Szydlo RM, Madrigal JA, Shaw BE) Transfusion 2016 May;56(5):1052-7 PMID: 26898844 02/24/2016
  • Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord. (Snowden JA, Danby R, Ruggeri A, Marks DI, Hough RE, Pagliuca A, Potter M, Russell N, Craddock C, Clark A, Miller P, Cook G, Gluckman E, Shaw BE, Rocha V) Br J Haematol 2016 Feb;172(3):478-81 PMID: 26708833 12/29/2015
  • Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors. (Arrieta-Bolaños E, Mayor NP, Marsh SG, Madrigal JA, Apperley JF, Kirkland K, Mackinnon S, Marks DI, McQuaker G, Perry J, Potter MN, Russell NH, Thomson K, Shaw BE) Haematologica 2016 Mar;101(3):382-90 PMID: 26611472 PMCID: PMC4815730 11/28/2015
  • European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. (Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE) Biol Blood Marrow Transplant 2016 Mar;22(3):514-9 PMID: 26597079 PMCID: PMC4760354 11/26/2015
  • Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. (Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV) Biol Blood Marrow Transplant 2016 Mar;22(3):520-7 PMID: 26597080 PMCID: PMC4760616 11/26/2015
  • Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols. (Hough R, Danby R, Russell N, Marks D, Veys P, Shaw B, Wynn R, Vora A, Mackinnon S, Peggs KS, Crawley C, Craddock C, Pagliuca A, Cook G, Snowden JA, Clark A, Marsh J, Querol S, Parkes G, Braund H, Rocha V) Br J Haematol 2016 Feb;172(3):360-70 PMID: 26577457 11/19/2015
  • Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening. (Lee JB, Billen A, Lown RN, Potter MN, Craddock CF, de Lavallade H, Shaw BE, Sharpe CC) Bone Marrow Transplant 2016 Feb;51(2):286-7 PMID: 26437069 10/06/2015
  • Sexual health in hematopoietic stem cell transplant recipients. (Li Z, Mewawalla P, Stratton P, Yong AS, Shaw BE, Hashmi S, Jagasia M, Mohty M, Majhail NS, Savani BN, Rovó A) Cancer 2015 Dec 01;121(23):4124-31 PMID: 26372459 PMCID: PMC5014908 09/16/2015
  • Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. (Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE) Bone Marrow Transplant 2016 Jan;51(1):83-8 PMID: 26367222 PMCID: PMC4570237 09/15/2015
  • Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association. (Bitan M, van Walraven SM, Worel N, Ball LM, Styczynski J, Torrabadella M, Witt V, Shaw BE, Seber A, Yabe H, Greinix HT, Peters C, Gluckman E, Rocha V, Halter J, Pulsipher MA) Biol Blood Marrow Transplant 2016 Jan;22(1):96-103 PMID: 26307344 08/27/2015
  • When Can You Discard Stem Cells? (Booth GS, Gehrie EA, Jagasia MH, Shaw BE, Savani BN) Biol Blood Marrow Transplant 2015 Nov;21(11):2033 PMID: 26253004 08/09/2015
  • Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. (Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2015 Oct;21(10):1830-8 PMID: 26116089 PMCID: PMC4568129 06/28/2015
  • Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. (Sriskandarajah P, Webb K, Chisholm D, Raobaikady R, Davis K, Pepper N, Ethell ME, Potter MN, Shaw BE) Thromb J 2015;13:21 PMID: 26113804 PMCID: PMC4480444 06/27/2015
  • Secondary solid cancer screening following hematopoietic cell transplantation. (Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers ME, Majhail NS) Bone Marrow Transplant 2015 Aug;50(8):1013-23 PMID: 25822223 PMCID: PMC4989866 03/31/2015
  • Novel alleles of the transforming growth factor β-1 regulatory region and exon 1. (Arrieta-Bolaños E, Madrigal JA, Shaw BE) Tissue Antigens 2015 Jun;85(6):484-91 PMID: 25808355 03/27/2015
  • Related hematopoietic cell donor care: is there a role for unrelated donor registries? (Anthias C, van Walraven SM, Sørensen BS, de Faveri GN, Fechter M, Cornish J, Bacigalupo A, Müller C, Boo M, Shaw BE) Bone Marrow Transplant 2015 May;50(5):637-41 PMID: 25730182 03/03/2015
  • A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies. (Shaw BE, Confer DL, Hwang W, Pulsipher MA) Bone Marrow Transplant 2015 Mar;50(3):334-40 PMID: 25599171 01/20/2015
  • Predonation health-related quality of life scores predict time to recovery in hematopoietic stem cell donors. (Billen A, Madrigal JA, Strydom A, Szydlo RM, Switzer GE, Shaw BE) Biol Blood Marrow Transplant 2015 Feb;21(2):350-6 PMID: 25452034 12/03/2014
  • The impact of improved JACIE standards on the care of related BM and PBSC donors. (Anthias C, Ethell ME, Potter MN, Madrigal A, Shaw BE) Bone Marrow Transplant 2015 Feb;50(2):244-7 PMID: 25387092 11/12/2014
  • A novel HLA-A allele, A*74:23, identified in an individual from Costa Rica. (Arrieta-Bolaños E, McWhinnie AJ, Madrigal-Sánchez JJ, Calvo L, Salazar-Sánchez L, Madrigal JA, Marsh SG, Shaw BE) Tissue Antigens 2014 Dec;84(6):583-4 PMID: 25345851 10/28/2014
  • Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation. (Shaw BE, Lee F, Krishnamurthy S, Byrne JL, Seedhouse C, Mayor NP, Maldonado-Torres H, Saudemont A, Marsh SG, Madrigal JA, Russell NH) Bone Marrow Transplant 2015 Feb;50(2):237-43 PMID: 25347010 10/28/2014
  • Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. (Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2015 Jan;21(1):165-71 PMID: 25316111 PMCID: PMC4272878 10/16/2014
  • A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent. (Scarisbrick JJ, Dignan FL, Tulpule S, Gupta ED, Kolade S, Shaw B, Evison F, Shah G, Tholouli E, Mufti G, Pagliuca A, Malladi R, Raj K) Bone Marrow Transplant 2015 Jan;50(1):62-7 PMID: 25310308 10/14/2014
  • Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study. (Nikolousis E, Nagra S, Pearce R, Perry J, Kirkland K, Byrne J, Dignan F, Tholouli E, Gilleece M, Russell N, Littlewood T, Cook M, Peniket A, Shaw BE, Cook G, Craddock C) Bone Marrow Transplant 2015 Jan;50(1):82-6 PMID: 25285801 10/07/2014
  • The frequency of HLA-B(∗)57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica. (Arrieta-Bolaños E, Madrigal JA, Marsh SG, Shaw BE, Salazar-Sánchez L) Hum Immunol 2014 Nov;75(11):1092-6 PMID: 25286002 10/07/2014
  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. (Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C) Blood 2014 Oct 16;124(16):2596-606 PMID: 25161269 PMCID: PMC4199961 08/28/2014
  • The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface. (Lee F, Luevano M, Veys P, Yong K, Madrigal A, Shaw BE, Saudemont A) PLoS One 2014;9(7):e103254 PMID: 25050704 PMCID: PMC4106894 07/23/2014
  • Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies. (Feliu J, Clay J, Raj K, Barber L, Devlia V, Shaw B, Pagliuca A, Mufti G) Br J Haematol 2014 Nov;167(3):426-8 PMID: 24962133 06/26/2014
  • Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1. (Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, Pollack MS, Reddy V, Senitzer D, Shaw BE, Waller EK, Lee SJ, Spellman SR) Bone Marrow Transplant 2014 Sep;49(9):1176-83 PMID: 24955785 PMCID: PMC4154997 06/24/2014
  • Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature. (Das-Gupta E, Dignan F, Shaw B, Raj K, Malladi R, Gennery A, Bonney D, Taylor P, Scarisbrick J) Bone Marrow Transplant 2014 Oct;49(10):1251-8 PMID: 24887389 06/03/2014
  • Female donors and donors who are lighter than their recipient are less likely to meet the CD34+ cell dose requested for peripheral blood stem cell transplantation. (Billen A, Madrigal JA, Szydlo RM, Shaw BE) Transfusion 2014 Nov;54(11):2953-60 PMID: 24863396 05/28/2014
  • Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. (Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL) Blood 2014 Jun 05;123(23):3655-63 PMID: 24735965 PMCID: PMC4047500 04/17/2014
  • Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee. (Lown RN, Philippe J, Navarro W, van Walraven SM, Philips-Johnson L, Fechter M, Pawson R, Bengtsson M, Beksac M, Field S, Yang H, Shaw BE, World Marrow Donor Association Clinical Working Group Committee) Bone Marrow Transplant 2014 Jul;49(7):880-6 PMID: 24710563 04/09/2014
  • Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD. (Dignan FL, Aguilar S, Scarisbrick JJ, Shaw BE, Potter MN, Cavenagh J, Apperley JF, Fielding AK, Pagliuca A, Raj K, Marks DI, Peniket A, Crawley C, Koh MB, Child FJ) Bone Marrow Transplant 2014 May;49(5):704-8 PMID: 24566709 02/26/2014
  • Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML. (Anthias C, Dignan FL, Morilla R, Morilla A, Ethell ME, Potter MN, Shaw BE) Bone Marrow Transplant 2014 May;49(5):679-83 PMID: 24510069 02/11/2014
  • A review of the haematopoietic stem cell donation experience: is there room for improvement? (Billen A, Madrigal JA, Shaw BE) Bone Marrow Transplant 2014 Jun;49(6):729-36 PMID: 24464144 01/28/2014
  • Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage. (Lown RN, Marsh SG, Switzer GE, Latham KA, Madrigal JA, Shaw BE) Bone Marrow Transplant 2014 Apr;49(4):525-31 PMID: 24419516 01/15/2014
  • EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. (Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S) Bone Marrow Transplant 2014 Feb;49(2):280-6 PMID: 24212561 11/12/2013
  • Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation. (Shaw BE, Chapman J, Fechter M, Foeken L, Greinix H, Hwang W, Phillips-Johnson L, Korhonen M, Lindberg B, Navarro WH, Szer J) Bone Marrow Transplant 2013 Nov;48(12):1506-9 PMID: 23892330 07/31/2013
  • Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest. (Lown RN, Tulpule S, Russell NH, Craddock CF, Roest R, Madrigal JA, Shaw BE) Haematologica 2013 Dec;98(12):1956-63 PMID: 23812935 PMCID: PMC3856971 07/03/2013
  • Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice. (Shaw BE, Robinson J, Fleischhauer K, Madrigal JA, Marsh SG) Bone Marrow Transplant 2013 Nov;48(12):1510-2 PMID: 23811815 07/03/2013
  • Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. (Medd PG, Peniket AJ, Littlewood TJ, Pearce R, Perry J, Kirkland KE, Shaw BE, Potter MN, Craddock CF, Milligan DW, Fielding AK, Marks DI, Cook G, British Society of Blood and Marrow Transplantation) Bone Marrow Transplant 2013 Jul;48(7):982-7 PMID: 23318533 01/16/2013
  • Biological and Genetic Aspects of Donor-Recipient Matching in HSCT. (Lange A, Raffoux C, Shaw B) Bone Marrow Res 2012;2012:212593 PMID: 23304517 PMCID: PMC3523404 01/11/2013
  • High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD. (Dignan FL, Potter MN, Ethell ME, Taylor M, Lewis L, Brennan J, McNamara L, Evans SO, Riley U, Davies FE, Dearden CE, Morgan GJ, Shaw BE) Clin Transplant 2013 Jan-Feb;27(1):E56-63 PMID: 23278853 01/03/2013
  • 16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. (Petersdorf EW, Malkki M, Hsu K, Bardy P, Cesbron A, Dickinson A, Dubois V, Fleischhauer K, Kawase T, Madrigal A, Morishima Y, Shaw B, Spellman S, Spierings E, Stern M, Tiercy JM, Velardi A, Gooley T, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Int J Immunogenet 2013 Feb;40(1):2-10 PMID: 23279968 PMCID: PMC3887040 01/03/2013
  • A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors. (Dignan FL, Manwani R, Potter MN, Ethell ME, Leonard H, Brennan J, Baker J, Shaw BE) Clin Transplant 2013 Jan-Feb;27(1):E1-2 PMID: 23215823 12/12/2012
  • Human leukocyte antigen profiles of latin american populations: differential admixture and its potential impact on hematopoietic stem cell transplantation. (Arrieta-Bolaños E, Madrigal JA, Shaw BE) Bone Marrow Res 2012;2012:136087 PMID: 23213535 PMCID: PMC3506882 12/06/2012
  • Allogeneic transplantation: when is a mismatch better than a match? (Shaw BE, Nolan A) Biol Blood Marrow Transplant 2013 Jan;19(1):1-2 PMID: 23151492 11/16/2012
  • NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome. (Mayor NP, Shaw BE, Madrigal JA, Marsh SG) Bone Marrow Res 2012;2012:180391 PMID: 23119165 PMCID: PMC3483648 11/03/2012
  • Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL) Blood 2013 Jan 03;121(1):197-206 PMID: 23109243 PMCID: PMC3538330 10/31/2012
  • 'First do no harm': where do we stand on unrelated hematopoietic cell donor safety? (Lown RN, Shaw BE) Expert Rev Hematol 2012 Jun;5(3):249-52 PMID: 22780204 07/12/2012
  • Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). (Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G, Shaw BE, Schmidt AH, Fechter M, Madrigal A, Szer J, Aljurf MD, Weisdorf D, Horowitz MM, Greinix H, Niederwieser D, Gratwohl A, Kodera Y, Confer D) Bone Marrow Transplant 2013 Feb;48(2):220-5 PMID: 22773129 07/10/2012
  • Diagnosis and management of acute graft-versus-host disease. (Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):30-45 PMID: 22533831 04/27/2012
  • Organ-specific management and supportive care in chronic graft-versus-host disease. (Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC, Shah P, Lightman S, Fortune F, Kibbler C, Andreyev J, Albanese A, Hadzic N, Potter MN, Shaw BE, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):62-78 PMID: 22533889 04/27/2012
  • Diagnosis and management of chronic graft-versus-host disease. (Dignan FL, Amrolia P, Clark A, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):46-61 PMID: 22533811 04/27/2012
  • A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. (Hollenbach JA, Madbouly A, Gragert L, Vierra-Green C, Flesch S, Spellman S, Begovich A, Noreen H, Trachtenberg E, Williams T, Yu N, Shaw B, Fleischhauer K, Fernandez-Vina M, Maiers M) Immunogenetics 2012 Aug;64(8):559-69 PMID: 22526601 PMCID: PMC3395342 04/25/2012
  • Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. (Lown RN, Shaw BE) Bone Marrow Transplant 2013 Feb;48(2):210-9 PMID: 22484322 04/10/2012
  • Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. (Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Lancet Oncol 2012 Apr;13(4):366-74 PMID: 22340965 PMCID: PMC3813000 02/22/2012
  • Transforming growth factor-β1 polymorphisms and the outcome of hematopoietic stem cell transplantation. (Arrieta-Bolaños E, Madrigal JA, Shaw BE) Int J Immunogenet 2012 Jun;39(3):192-202 PMID: 22284668 01/31/2012
  • Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. (Dignan FL, Greenblatt D, Cox M, Cavenagh J, Oakervee H, Apperley JF, Fielding AK, Pagliuca A, Mufti G, Raj K, Marks DI, Amrolia P, Peniket A, Medd P, Potter MN, Shaw BE, Scarisbrick JJ) Bone Marrow Transplant 2012 Jun;47(6):824-30 PMID: 21927038 09/20/2011
  • Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. (Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN) Hematology 2011 Jul;16(4):213-20 PMID: 21756537 07/16/2011
  • Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. (Shaw BE, Confer DL, Hwang WY, Pamphilon DH, Pulsipher MA) Haematologica 2011 Jul;96(7):942-7 PMID: 21719883 PMCID: PMC3128211 07/02/2011
  • Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. (Shaw BE, Apperley JF, Russell NH, Craddock C, Liakopoulou E, Potter MN, Wynn R, Gibson B, Pearce RM, Kirkland K, Lee J, Madrigal JA, Cook G, Byrne JL) Br J Haematol 2011 Apr;153(2):244-52 PMID: 21382020 03/09/2011
  • WMDA guidelines for subsequent donations following initial BM or PBSCs. (Confer DL, Shaw BE, Pamphilon DH, Clinical Working Group of the WMDA) Bone Marrow Transplant 2011 Nov;46(11):1409-12 PMID: 21297674 02/08/2011
  • An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. (Mohammed K, Dignan F, Ethell ME, Davies FE, Morgan GJ, Riley U, Evans S, Potter MN, Shaw BE) Leuk Lymphoma 2011 Feb;52(2):339-40 PMID: 21281242 02/02/2011
  • Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. (Boo M, van Walraven SM, Chapman J, Lindberg B, Schmidt AH, Shaw BE, Switzer GE, Yang E, Egeland T, World Marrow Donor Association) Blood 2011 Jan 06;117(1):21-5 PMID: 20921337 10/06/2010
  • A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. (Kanga U, McWhinnie AJ, Mourya M, Shaw BE, Madrigal JA, Mehra NK) Tissue Antigens 2011 Jan;77(1):85-7 PMID: 20887382 10/05/2010
  • The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. (Shaw BE, Arguello R, Garcia-Sepulveda CA, Madrigal JA) Br J Haematol 2010 Aug;150(3):251-8 PMID: 20560963 06/22/2010
  • First do no harm. (Shaw BE) Blood 2010 Jun 17;115(24):4978-9 PMID: 20558623 06/19/2010
  • Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. (Duarte RF, Shaw BE, Marín P, Kottaridis P, Ortiz M, Morante C, Delgado J, Gayoso J, Goterriz R, Martínez-Chamorro C, Mateos-Mazón JJ, Ramírez C, de la Rubia J, Achtereekte H, Gandhi PJ, Douglas KW, Russell NH) Bone Marrow Transplant 2011 Jan;46(1):52-8 PMID: 20305700 03/23/2010
  • Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. (Hiwarkar P, Shaw BE, Tredger JM, Brown NW, Kulkarni S, Saso R, Evans S, Treleaven J, Davies FE, Ethell ME, Morgan GJ, Potter MN) Clin Transplant 2011 Mar-Apr;25(2):222-7 PMID: 20201951 03/06/2010
  • Unrelated hematopoietic stem cell donors as research subjects. (King RJ, Confer DL, Greinix HT, Halter J, Horowitz M, Schmidt AH, Costeas P, Shaw B, Egeland T, Ethics and Clinical Working Groups of World Marrow Donor Association) Bone Marrow Transplant 2011 Jan;46(1):10-3 PMID: 20190845 03/02/2010
  • Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. (Shaw BE, Ball L, Beksac M, Bengtsson M, Confer D, Diler S, Fechter M, Greinix H, Koh M, Lee S, Nicoloso-De-Faveri G, Philippe J, Pollichieni S, Pulsipher M, Schmidt A, Yang E, van Walraven AM, Clinical Working Group, Ethics Working Group of the WMDA) Bone Marrow Transplant 2010 May;45(5):832-8 PMID: 20173787 02/23/2010
  • Family donor care management: principles and recommendations. (van Walraven SM, Nicoloso-de Faveri G, Axdorph-Nygell UA, Douglas KW, Jones DA, Lee SJ, Pulsipher M, Ritchie L, Halter J, Shaw BE, WMDA Ethics and Clinical working groups) Bone Marrow Transplant 2010 Aug;45(8):1269-73 PMID: 20023708 12/22/2009
  • Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. (Shaw BE, Mayor NP, Russell NH, Apperley JF, Clark RE, Cornish J, Darbyshire P, Ethell ME, Goldman JM, Little AM, Mackinnon S, Marks DI, Pagliuca A, Thomson K, Marsh SG, Madrigal JA) Leukemia 2010 Jan;24(1):58-65 PMID: 19924143 11/20/2009
  • Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. (Berro M, Mayor NP, Maldonado-Torres H, Cooke L, Kusminsky G, Marsh SG, Madrigal JA, Shaw BE) Haematologica 2010 Feb;95(2):276-83 PMID: 19713222 PMCID: PMC2817031 08/29/2009
  • Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. (Patel B, Kirkland KE, Szydlo R, Pearce RM, Clark RE, Craddock C, Liakopoulou E, Fielding AK, Mackinnon S, Olavarria E, Potter MN, Russell NH, Shaw BE, Cook G, Goldstone AH, Marks DI) Haematologica 2009 Oct;94(10):1399-406 PMID: 19648167 PMCID: PMC2754956 08/04/2009
  • Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? (Querol S, Mufti GJ, Marsh SG, Pagliuca A, Little AM, Shaw BE, Jeffery R, Garcia J, Goldman JM, Madrigal JA) Haematologica 2009 Apr;94(4):536-41 PMID: 19229051 PMCID: PMC2663617 02/21/2009
  • The impact of extramedullary disease at presentation on the outcome of myeloma. (Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, Potter MN, Ethell ME, Shaw BE, Morgan GJ) Leuk Lymphoma 2009 Feb;50(2):230-5 PMID: 19197724 02/07/2009
  • Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. (Tulpule S, Shaw BE, Makoni P, Little AM, Madrigal JA, Goldman JM) Bone Marrow Transplant 2009 Jul;44(2):129-30 PMID: 19151798 01/20/2009
  • Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. (Shaw BE, Veys P, Pagliuca A, Addada J, Cook G, Craddock CF, Gennery AR, Goldman J, Mackinnon S, Madrigal JA, Marks DI, Navarrete C, Potter MN, Querol S, Regan F, Russell NH, Hough RE) Bone Marrow Transplant 2009 Jul;44(1):7-12 PMID: 19139741 01/14/2009
  • An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. (Dignan FL, Evans SO, Ethell ME, Shaw BE, Davies FE, Dearden CE, Treleaven JG, Riley UB, Morgan GJ, Potter MN) Bone Marrow Transplant 2009 Jul;44(1):51-6 PMID: 19139735 01/14/2009
  • The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation. (Shaw BE) Int J Immunogenet 2008 Aug;35(4-5):367-74 PMID: 18976440 11/04/2008
  • Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. (Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE, Apperley JF, Chakraverty R, Craddock CF, Kazmi MA, Littlewood TJ, Milligan DW, Pagliuca A, Thomson KJ, Marks DI, Russell NH) Bone Marrow Transplant 2008 Dec;42(12):783-9 PMID: 18724393 08/30/2008
  • No impact of NOD2/CARD15 on outcome after SCT: a reply. (Mayor NP, Shaw BE, Madrigal JA, Marsh SG) Bone Marrow Transplant 2008 Dec;42(12):837-8 PMID: 18695658 08/13/2008
  • Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE. (Srikanth M, Davies FE, Wu P, Jenner MW, Ethell ME, Potter MN, Shaw BE, Saso RM, Dines S, Morgan GJ) Eur J Haematol 2008 Dec;81(6):432-6 PMID: 18691254 08/12/2008
  • Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia. (Tholouli E, Liakopoulou E, Greenfield HM, Shaw BE, Tauro S, Byrne JL, Dennis M, Burthem J, Lucas GS, Craddock C, Russell NH, Liu Yin JA) Br J Haematol 2008 Jun;142(2):318-20 PMID: 18492100 05/22/2008
  • Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma. (Ingram W, Devereux S, Das-Gupta EP, Russell NH, Haynes AP, Byrne JL, Shaw BE, McMillan A, Gonzalez J, Ho A, Mufti GJ, Pagliuca A) Br J Haematol 2008 Apr;141(2):235-43 PMID: 18318762 03/06/2008
  • Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. (Madrigal A, Shaw BE) Blood Cells Mol Dis 2008 Jan-Feb;40(1):40-3 PMID: 17964196 10/30/2007
  • Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant. (Shaw BE, Russell NH) Bone Marrow Transplant 2008 Mar;41(5):495-503 PMID: 17952130 10/24/2007
  • The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. (Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringdén O, Marsh SG, Petersdorf EW) Blood 2007 Dec 15;110(13):4560-6 PMID: 17726164 08/30/2007
  • Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. (Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S, Marsh SG) J Clin Oncol 2007 Sep 20;25(27):4262-9 PMID: 17724347 08/29/2007
  • A novel technique for NOD2/CARD15 genotyping using PCR-SSP. (Mayor NP, Shaw BE, Keshav S, Madrigal JA, Marsh SG) J Immunol Methods 2007 Oct 31;327(1-2):82-7 PMID: 17719603 08/28/2007
  • Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab. (Das-Gupta EP, Russell NH, Shaw BE, Pearce RM, Byrne JL) Biol Blood Marrow Transplant 2007 Jun;13(6):724-33 PMID: 17531783 05/29/2007
  • The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants. (Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH) Biol Blood Marrow Transplant 2007 May;13(5):550-9 PMID: 17448914 04/24/2007
  • Clinical importance of HLA-DPB1 in haematopoietic cell transplantation. (Shaw BE, Gooley T, Madrigal JA, Malkki M, Marsh SG, Petersdorf EW) Tissue Antigens 2007 Apr;69 Suppl 1:36-41 PMID: 17445160 04/21/2007
  • Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. (Shaw BE, Boswell T, Byrne JL, Yates C, Russell NH) Bone Marrow Transplant 2007 May;39(10):623-9 PMID: 17384657 03/27/2007
  • Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease. (Bishton MJ, Lush RJ, Byrne JL, Russell NH, Shaw BE, Haynes AP) Br J Haematol 2007 Mar;136(5):752-61 PMID: 17313378 02/23/2007
  • Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. (Duarte RF, Pamphilon D, Cornish J, Shaw BE, Samson D, Craddock C, Marks D, Mufti GJ, Powles RL, Apperley JF, Madrigal JA, Goldman JM) Bone Marrow Transplant 2006 May;37(10):901-8 PMID: 16670700 05/04/2006
  • The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. (Shaw BE, Russell NH, Devereux S, Das-Gupta E, Mackinnon S, Madrigal JA, Pagliuca A, Mufti GJ, Byrne JL) Haematologica 2005 Nov;90(11):1562-9 PMID: 16266905 11/04/2005
  • HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. (Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA) Blood 2006 Feb 01;107(3):1220-6 PMID: 16234356 10/20/2005
  • Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. (Duarte RF, Delgado J, Shaw BE, Wrench DJ, Ethell M, Patch D, Dhillon AP, Mackinnon S, Potter MN, Quaglia AF) Biol Blood Marrow Transplant 2005 Oct;11(10):805-13 PMID: 16182181 09/27/2005
  • Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. (Kröger N, Shaw B, Iacobelli S, Zabelina T, Peggs K, Shimoni A, Nagler A, Binder T, Eiermann T, Madrigal A, Schwerdtfeger R, Kiehl M, Sayer HG, Beyer J, Bornhäuser M, Ayuk F, Zander AR, Marks DI, Clinical Trial Committee of the British Society of Blood and Marrow Transplantation and the German Cooperative Transplant Group) Br J Haematol 2005 Jun;129(5):631-43 PMID: 15916686 05/27/2005
  • Sequence of a novel HLA-A*0301 intronic variant (A*03010103). (Mayor NP, Cox ST, McWhinnie AJ, Argüello JR, Shaw BE, Little AM, Madrigal JA, Marsh SG) Tissue Antigens 2005 Jan;65(1):107-9 PMID: 15663748 01/25/2005
  • Scoring for HLA matching? A clinical test of HistoCheck. (Shaw BE, Barber LD, Madrigal JA, Cleaver S, Marsh SG) Bone Marrow Transplant 2004 Aug;34(4):367-8; author reply 369 PMID: 15195082 06/15/2004
  • Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. (Shaw BE, Maldonado H, Madrigal JA, Smith C, Petronzelli F, Mayor NP, Potter MN, Bodmer JG, Marsh SG) Tissue Antigens 2004 May;63(5):401-11 PMID: 15104672 04/24/2004
  • The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. (Shaw BE, Peggs K, Bird JM, Cavenagh J, Hunter A, Alejandro Madrigal J, Russell NH, Sirohi B, Towlson K, Williams CD, Marks DI, Clinical Trials Committee of the British Society of Blood and Marrow Transplantation) Br J Haematol 2003 Dec;123(5):886-95 PMID: 14632780 11/25/2003
  • The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. (Shaw BE, Potter MN, Mayor NP, Pay AL, Smith C, Goldman JM, Prentice HG, Marsh SG, Madrigal JA) Bone Marrow Transplant 2003 Jun;31(11):1001-8 PMID: 12774051 05/30/2003
  • Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. (Shaw B, Mehta AB) Clin Lab Haematol 2002 Dec;24(6):385-7 PMID: 12452820 11/28/2002
  • Improving the outcome of unrelated donor stem cell transplantation by molecular matching. (Shaw BE, Madrigal JA, Potter M) Blood Rev 2001 Dec;15(4):167-74 PMID: 11792117 01/17/2002
  • Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy. (Shaw BE, Perry D, Hoffbrand AV) Leuk Lymphoma 2001 Jun;42(1-2):221-3 PMID: 11699211 11/09/2001
  • Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. (Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C, Neumeister P, Finazzi G, Iacobelli M, Bowyer K, Prentice HG, Barbui T) Br J Haematol 2000 Dec;111(4):1122-9 PMID: 11167751 02/13/2001
  • Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation. (Paterson PJ, Marshall SR, Shaw B, Kendra JR, Ethel M, Kibbler CC, Prentice HG, Potter M) Bone Marrow Transplant 2000 Sep;26(6):701-3 PMID: 11041574 10/21/2000
  • Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression. (Somers LJ, Shaw B, Lyn BE, McMillan AM, Mahendra P) Clin Lab Haematol 1998 Jun;20(3):189-90 PMID: 9681237 07/29/1998
  • Last update: 11/15/2017
    jenkins-FCD Prod-153 3ca6710ea990189ceb85f4312e7298b5922ce1a6